Dear subscriber,
We're sending you this email to let you know that we have updated our privacy policy [Link] and terms of service [Link] in order to comply with the new EU General Data Protection Regulation (GDPR) which determines how we process your personal data.
Whilst GDPR is designed to protect the personal data of EU citizens, we are applying the same policies to all of our customers globally. Therefore we need your permission to store the necessary personal information in our records if you don't want to miss future newsletters, offers or other information. All you have to do is to give your consent.
Do you want to receive information from SQUARIX even in the future?
By clicking the box below you agree that we will continue to communicate with you, as well as giving us the consent that we store your personal information for this use.
|
SQUARIX GmbH is a science driven product and service oriented privately held biotechnology company, offering high purity Discovery Chemicals, Innovative Reagents and Antibody Technology Services for the biomedical market.
Since 1992, SQUARIX produces a broad product line of compounds that include innovative building blocks, reactive intermediates, natural products and derivatives, screening compounds for drug discovery industry and reagents for life science applications comprising polyclonal and monoclonal antibodies, metabolic intermediates.
|